Aytu Biopharma (AYTU) Interest & Investment Income (2019 - 2020)
Aytu Biopharma's (AYTU) quarterly Interest & Investment Income came in at -$378958.0 in Q4 2020, up 15.21% year-over-year from -$328916.7 in Q1 2020, and up 29.67% quarter-over-quarter from -$538862.0 in Q1 2020.
Powered by 
Analysis
Aytu Biopharma (AYTU) Interest & Investment Income (2019 - 2020) Analysis & Trends
Aytu Biopharma (AYTU) has reported Interest & Investment Income for 2 consecutive years, with -$378958.0 the latest figure, recorded in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.50 Bn | 622.74 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 440.29 Bn | 433.72 Bn | 12.70 Bn | -679.00 Mn |
| 3 | Merck | 364.93 Bn | 357.79 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.65 Bn | 258.96 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.92 Bn | 147.22 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 89.50 Mn |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - | 35.58 Mn |
| 8 | Incyte | 25.32 Bn | 20.78 Bn | 1.57 Bn | 38.12 Mn |
| 9 | United Therapeutics | 21.42 Bn | 18.75 Bn | 683.80 Mn | 31.50 Mn |
| 10 | Aytu Biopharma | 22.71 Mn | -4.01 Mn | 7.60 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | -378,958.00 |
| Mar 31, 2020 | -538,862.00 |
| Dec 31, 2019 | -446,958.00 |